Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05750706Completed

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Role: collaborator

NCT03353311Completed

ERAS Lazio Network Clinical Registry

Role: collaborator

NCT05888636Recruiting

Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma

Role: collaborator

NCT05164887Completed

Microbiota Implementation to Reduce Anastomotic Colorectal Leaks (MIRACLe)

Role: lead

NCT05711966Not ApplicableRecruiting

Comparison of INRECSURE and LISA in Preterm Neonates With RDS

Role: collaborator

NCT01831323Unknown

Evaluation of the Metabolome in Diverticular Disease

Role: lead

All 6 trials loaded